Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-21

Clinical Trial Update: In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)

View source ↗

Summary

Completed clinical trial investigating in-situ cytokine expression in the central nervous system of patients with amyotrophic lateral sclerosis (ALS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brugmann University Hospital | Conditions: Amyotrophic Lateral Sclerosis | Status: COMPLETED